FindTrial
Sign In

A study to find out clinical outcomes with variable durations of testosterone local application gel as pretreatment in patients with suspected poor results in IVF cycles

A Randomized Controlled Trial to assess the clinical outcomes with different durations of Transdermal Testosterone gel as pretreatment in patients with Poor prognosis in Antagonist IVF/ICSI cycles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040793
Enrollment
100
Registered
2022-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: TRANSDERMAL TESTOSTERONE GEL: 1.25gm testosterone gel once daily(12.5mg testosterone) GIVEN FOR 2,3 AND 4 WEEKS AS PRETREATMENT Control Intervention1: no pretreatment: GEL NOT GIVEN bef

Sponsors

DRKD NAYAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: antral follicle count less than 5 anti mullerian hormone less than/ equal to 1.1ng/ml

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
CLINICAL PREGNANCY RATETimepoint: CARDIAC ACTIVITY AT 7WEEKS after last menstrual period—

Secondary

MeasureTime frame
No. of mature oocytes miscarriage rates ongoing pregnancy rates fertilization rate implantation rateTimepoint: 7months—

Countries

India

Contacts

Public ContactDRGARIMA KAUR

AKANKSHA IVF CENTRE

kdnayar@usa.net9810398765

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026